GREGORY MICHAEL PFITZER
Allopathic & Osteopathic Physicians|Family Medicine SHERMAN, TX NPI 1396199147
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$293.27
- Category: General Payments
- Program years: PY2018–2021
- Record count: 14
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $114.87 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $114.87 | 8 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $70.08 | 5 |
| Gilead Sciences, Inc. | $44.79 | 3 |
By program year
Records — PY2021 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 829545961 | AstraZeneca Pharmaceuticals LP | $13.34 | 07/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829773355 | AstraZeneca Pharmaceuticals LP | $16.70 | 05/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829901455 | AstraZeneca Pharmaceuticals LP | $13.36 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 830094101 | AstraZeneca Pharmaceuticals LP | $13.34 | 10/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 830252627 | AstraZeneca Pharmaceuticals LP | $13.34 | 08/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 848258139 | Gilead Sciences, Inc. | $13.77 | 08/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 848258141 | Gilead Sciences, Inc. | $15.49 | 09/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 848258143 | Gilead Sciences, Inc. | $15.53 | 12/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.